Reynolds Capital Management’s Biogen BIIB Stock Holding History

Reynolds Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$286K	Sell	1,100 -3,100	-74%	-$819K	0.5%	66
2015 Q4	$1.29M	Buy	4,200 +1,500	+56%	+$431K	1.4%	15
2015 Q3	$788K	Buy	2,700 +600	+29%	+$198K	0.99%	25
2015 Q2	$848K	Sell	2,100 -1,300	-38%	-$522K	0.83%	22
2015 Q1	$1.44M	Buy	3,400 +200	+6%	+$78.8K	1.25%	8
2014 Q4	$1.09M	Buy	3,200 +400	+14%	+$129K	0.9%	20
2014 Q3	$926K	Sell	2,800 -100	-3%	-$33K	0.9%	19
2014 Q2	$914K	Buy	2,900 +400	+16%	+$120K	0.62%	23
2014 Q1	$765K	Buy	2,500 +200	+9%	+$63.5K	0.49%	26
2013 Q4	$643K	Hold	2,300	–	–	0.36%	60
2013 Q3	$554K	Buy	+2,300	New	+$515K	0.36%	59

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Reynolds Capital Management's BIIB Position: Q1 2016 in Review

Reynolds Capital Management reduced its Biogen (BIIB) stake by 74% in Q1 2016, selling an estimated $819K and leaving 1,100 shares worth $286K. The position accounts for 0.5% of the portfolio, ranked #66.

Reynolds Capital Management first reported a position in BIIB in Q3 2013 and has held it in 11 quarters since. The position peaked at $1.44M in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

Reynolds Capital Management held 1,100 shares of Biogen worth $286K as of Q1 2016.
Reynolds Capital Management sold 3,100 Biogen shares in Q1 2016, an estimated $819K.
Biogen made up 0.5% of Reynolds Capital Management's portfolio in Q1 2016, its #66 holding.
Reynolds Capital Management first reported a position in Biogen in Q3 2013 and has held it in 11 quarters since.
Reynolds Capital Management's Biogen position peaked at $1.44M in Q1 2015.
948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.